D
C
D07CC05 Fluocinonide and antibiotics
[D07CC] Corticosteroids, potent, combinations with antibiotics
[D07C] CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
[D07] CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
[D] Dermatological drugs
D07AC08 Fluocinonide
[D07AC] Corticosteroids, potent (group III)
[D07A] CORTICOSTEROIDS, PLAIN
[D07] CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
[D] Dermatological drugs
C05AA11 Fluocinonide
[C05AA] Corticosteroids
[C05A] AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
[C05] VASOPROTECTIVES
[C] Cardiovascular system
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | human | qHTS-HepG2 | MMP assay | Negative | IC50 | 163 | ||
| MEMBRANE POTENTIAL | human | HepG2 | MMP assay | Negative | IC50 | 163 | ||
| MEMBRANE POTENTIAL | rat | hepatocytes | MMP assay | Negative | IC50 | 163 | ||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
![]() ![]() |
Danger |
Aggregated GHS information provided by 42 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral] H361 (97.62%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P264, P270, P281, P301+P310, P308+P313, P321, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| (6ALPHA,11BETA,16ALPHA)-21-(ACETYLOXY)-6,9-DIFLUORO-11-HYDROXY-16,17-[(1-METHYLETHYLIDENE)BIS(OXY)]-PREGNA-1,4-DIENE-3,20-DIONE | 1,4-PREGNADIEN-6ALPHA,9ALPHA-DIFLUORO-11BETA,16ALPHA,17,21-TETROL-3,20-DIONE 16,17-ACETONIDE 21-ACETATE | 2-((2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate |
| 2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl acetate; | 20527-EP2371811A2 | 2W4A77YPAN |
| 356-12-7 | 356F127 | 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone, 21-acetate |
| AB2000697 | ABP000638 | AC-2071 |
| AKOS015896516 | API0002731 | BCP9000697 |
| BPBio1_000934 | BRD-K57886322-001-03-4 | BRD-K57886322-001-12-5 |
| BSPBio_000848 | Bestasone | Biscosal |
| C07007 | C26H32F2O7 | CAS-356-12-7 |
| CCG-220774 | CHEBI:5109 | CHEMBL1501 |
| CS-2601 | Cortalar | D00325 |
| DB01047 | DSSTox_CID_25307 | DSSTox_GSID_45307 |
| DSSTox_RID_80793 | DTXSID8045307 | EINECS 206-597-6 |
| FLUOCINOMIDE ACETATE | FLUOCINONIDE ACETONIDE 21-ACETATE | Fluocinolide |
| Fluocinolide acetate | Fluocinolone acetonide 21-acetate | Fluocinolone acetonide acetate |
| Fluocinonide (JP17/USP/INN) | Fluocinonide (Vanos) | Fluocinonide Emulsified Base |
| Fluocinonide FAPG | Fluocinonide [USAN:BAN:INN:JAN] | Fluocinonide [USAN:INN:BAN:JAN] |
| Fluocinonide [USAN:USP:INN:BAN:JAN] | Fluocinonide(Vanos) | Fluocinonide(Vanos)/ |
| Fluocinonide, >=98% (HPLC) | Fluocinonide, United States Pharmacopeia (USP) Reference Standard | Fluocinonide, micronised |
| Fluocinonido | Fluocinonido [INN-Spanish] | Fluocinonidum |
| Fluocinonidum [INN-Latin] | Fluonex | Fluonex;Lidex;Lidex-E;Lonide;Lyderm;Vanos |
| GTPL7078 | HMS1570K10 | HMS2097K10 |
| HMS2234H04 | HMS3259N05 | HMS3714K10 |
| HY-B0485 | LIDEX (TN) | LIDEX-E |
| LS-118446 | Lidex | Lidex E |
| Lonide | Lyderm | MFCD00079302 |
| MLS000028476 | Metosyn | NC00621 |
| NCGC00016436-01 | NCGC00022398-03 | NCGC00022398-05 |
| NSC 101791 | Opera_ID_1780 | Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 6-alpha, 9-difluoro-11-beta,16-alpha,17,21-tetrahydroxy-, cyclic17-acetal with acetone, 21-acetate | Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone, 21-acetate | Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone, 21-acetate (8CI) |
| Prestwick0_000774 | Prestwick1_000774 | Prestwick2_000774 |
| Prestwick3_000774 | Prestwick_1066 | Q5462791 |
| SC-78862 | SCHEMBL4262 | SMR000058331 |
| SPBio_002787 | SR-01000003097 | SR-01000003097-3 |
| Straderm | Synalar acetate | Topsymin |
| Topsyn | Tox21_110438 | Tox21_110438_1 |
| UNII-2W4A77YPAN | Vanos | Vanos (TN) |
| W-106660 | YF10077 | ZINC3977978 |
| fluocinonide | s2608 |